Search the site for any medical term or simply browse by disease topic. Access all the information you need in one place, when you need it, how you want it and for free!
Launch of accredited Type 1 Childhood Diabetes CME
A new EACCME-accredited CME activity Individual Patient Management in Type 1 Childhood Diabetes has launched on epgonline.org. Intended for medical professionals involved in the management of young patients with type 1 diabetes, this module consists of six sessions, each covering a different aspect of managing psychosocial issues in type 1 childhood diabetes.
Explore at your own pace and test your knowledge using the interactive learning exercises. The activity is totally free, and on completion you will be awarded 1 European CME credit (ECMEC).
Anti-Infectives Knowledge Network (AIKN) CDI Updates
Recently updated with new reports and policy updates as well as key perspectives on Clostridium difficile infection (CDI), the Anti-Infectives Knowledge Network shares expertise and experience in the area of anti-infectives.
This educational resource is an initiative by Astellas Pharma EMEA. Please remember to return often to read the news, clinical insights, and essential information from the latest anti-infective congresses.
January 2015 FDX/15/0003/EU
This free CME activity covers the best practice management of nocturnal enuresis through three case study-led modules, including a more severe and complex patient scenario. It is intended for Urologists, Paediatricians, Primary Care Providers and General Practitioners looking to improve their understanding and management of bedwetting.
Accredited Obesity CME
The EACCME accredited European Obesity Initiative eCME module – Understanding Obesity, is freely accessible to healthcare professionals. Upon successful completion, participants will be awarded 2 European CME credits (ECMECs) and have a broad understanding of the epidemiology, contributory factors and management options for patients with obesity.
Type 2 Diabetes accredited CME
‘Role of Newer Therapies for Type 2 Diabetes in Combination with Insulin’ is EACCME accredited and awarded 1 European CME credit (ECMEC). There are 3 modules:
- A Review of Newer Therapies for Type 2 Diabetes in Combination with Insulin; John Wilding (Chair)
- Identifying and Managing the Psychosocial Aspects of Type 2 Diabetes Mellitus; Richard Holt (Faculty)
- Potential Role of Newer Therapies for Type 2 Diabetes in Combination with Insulin: Interactive Case Discussion; Bernard Charbonnel (Faculty)
The European Union’s Committee for Medicinal Products for Human Use has issued a positive opinion on the use of Avastin (bevacizumab), from Roche, in combination with standard chemotherapy (paclitaxel and cisplatin or, alternatively, paclitaxel ...
Bristol-Myers Squibb announced that the FDA has accepted for filing and review the Biologics Licensing Application (BLA) for Opdivo (nivolumab) for the treatment of patients with advanced squamous non-small cell lung cancer (NSCLC) after prior ...
CHMP recommends Toujeo (insulin glargine [rDNA origin]) for treatment of type 1 and type 2 diabetes-Sanofi01-Mar-2015
Sanofi has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Toujeo (insulin glargine [rDNA origin] injection, 300 U/mL), a ...
The committee for medicinal products for human use of the European Medicines Agency has adopted a positive opinion to extend the marketing authorization for Vectibix (panitumumab), from Amgen, to include combination with FOLFIRI (irinotecan-based ...
The Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended Jinarc (tolvaptan), from Otsuka Pharmaceutical, for approval to slow the progression of cyst development and renal insufficiency of autosomal dominant ...
The Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion to update the therapeutic indication for Soliris (eculizumab), from Alexion, in the treatment of paroxysmal nocturnal haemoglobinuria ...
The Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion to update the therapeutic indication for Soliris (eculizumab), from Alexion, with additional data on the benefits of long-term ...